20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Review article

Consensus on molecular imaging and theranostics in prostate cancer

Fanti, S., Minozzi, S., Antoch, G., Banks, I., Briganti, A., Carrio, I., Chiti, A., Clarke, N., Eiber, M., de Bono, J., Fizazi, K., Gillessen, S., Gledhill, S., Haberkorn, U., Herrmann, K., Hicks, R. J., Lecouvet, F., Montironi, R., Ost, P., O'Sullivan, J. M. & 11 others, Padhani, A. R., Schalken, J. A., Scher, H. I., Tombal, B., van Moorselaar, R. J. A., van Poppel, H., Vargas, H. A., Walz, J., Weber, W. A., Wester, H-J. R. & Oyen, W. J. G., 2018, In : The Lancet Oncology. 19, 12, p. e696-e708

Research output: Contribution to journalReview articleAcademicpeer-review

First-line non-cytotoxic therapy in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of 10 randomised clinical trials

Poorthuis, M. H. F., Vernooij, R. W. M., van Moorselaar, R. J. A. & de Reijke, T. M., Jun 2017, In : BJU International. 119, 6, p. 831-845 15 p.

Research output: Contribution to journalReview articleAcademicpeer-review

New experimental markers for early detection of high-risk prostate cancer: Role of cell-cell adhesion and cell migration

Mol, A. J. M., Geldof, A. A., Meijer, G. A., Van Der Poel, H. G. & Van Moorselaar, R. J. A., 1 Oct 2007, In : Journal of Cancer Research and Clinical Oncology. 133, 10, p. 687-695 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Report

Beperkte update richtlijn prostaatcarcinoom: een overzicht van de wijzigingen in 2016: Limited update guideline prostate cancer: an overview of the changes in 2016

de Groot, J. J. F., van Moorselaar, RJA., Coenen, J. L., Gietema, J. A., Vogel, W. V. & de Reijke, T. M., 2016, Nederlands Tijdschrift voor Oncologie. 254 p.

Research output: Book/ReportReportProfessional

Plasma FGF23 is not elevated in prostate cancer

Vlot, M. C., Bijnsdorp, I., den Heijer, M., de Jonge, R., van Moorselaar, R. J. A. & Heijboer, A. C., 1 Mar 2018, In : Clinica Chimica Acta. 478, p. 129-131 3 p.

Research output: Contribution to journalLetterAcademicpeer-review

Comment/Letter to the editor

Case Presentation: Botox Versus Nerve Stimulation

van Moorselaar, R. J. A. & Nieuwenhuijzen, J. A., 1 Dec 2017, In : European Urology Focus. 3, 6, p. 529-530 2 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Case Presentation: Neurogenic Bladder in a Girl After Surgery for Cloacal Malformation

Beckers, G. M. A. & van Moorselaar, R. J. A., 1 Apr 2017, In : European Urology Focus. 3, 2-3, p. 158-160 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Case Presentation: Mycotic Aortic Aneurysm and Psoas Abscess as a Complication of Bacillus Calmette-Guérin Instillations

van Moorselaar, R. J. A. & Wisselink, W., 1 Oct 2016, In : European Urology Focus. 2, 4, p. 351-353 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Clinical Case Discussion: Kidney Stone in a Patient with an Ileal Conduit

van Moorselaar, R. J. A. & Nieuwenhuijzen, J. A., 1 Feb 2017, In : European Urology Focus. 3, 1, p. 13 1 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Commentaar op artikel "PSMA PET voor beeldvorming van prostaatkanker en metastasen van prostaatkanker”

de Reijke, T. & van Moorselaar, RJA., 2016, In : Nederlands Tijdschrift voor Geneeskunde. 160, p. D385

Research output: Contribution to journalComment/Letter to the editorProfessional

Chapter

Advanced and metastatic prostate cancer, new results of clinical trials

van Moorselaar, R. J. A., 2012, Course book ESU Course: What's new in prostate cancer and female urology. p. 64-81

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Case on Rectovesical Fistula After LAR

Cuesta, M. A. & van Moorselaar, R. J. A., 2014, Case Studies of Postoperative Complications after Digestive Surgery. p. 433-437

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

High-risk non-metastatic prostate cancer. Summary of Science for Practice

Bellmunt, J., van Moorselaar, RJA. & Wiegel, T., 2016, E-HIMS bvba.

Research output: Chapter in Book/Report/Conference proceedingChapterProfessional

Hormonale therapie

van Moorselaar, R. J. A., 2009, Handboek prostaataandoeningen. Utrecht: De Tijdstroom, p. 487-494

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Localised prostate cancer, there is more than robotic surgery

van Moorselaar, R. J. A., 2012, Course book ESU Course: What's nw in prostate cancer and female urology. p. 64-81

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Metastatic prostate cancer. Summary of Science for Practice

Bellmunt, J., van Moorselaar, RJA. & Wiegel, T., 2016, E-HIMS bvba.

Research output: Chapter in Book/Report/Conference proceedingChapterProfessional

Outcomes and complications of different radical therapies: are we comparing apples with oranges?

Dearneley, D., Khoo, V., van Moorselaar, R. J. A. & Stranne, J., 2015, Mirrors of Medicine. Summary of science for practice. Localised prostate cancer: initial management of low- and intemediate- risk disease. E-HIMS bvba, p. 31-62

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Pijnlijke mictie

Nieuwenhuijzen, J. A. & van Moorselaar, R. J. A., 2013, Leerboek Urologie. Bohn Stafleu van Loghum, p. 43-56

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Prostaatkanker

van Moorselaar, R. J. A., Piet, A. H. M. & Gerritsen, W. R., 2012, Handboek kanker bij ouderen. De Tijdstroom, p. 241-248

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

PSA

van Moorselaar, R. J. A., 2009, Handboek prostaataandoeningen. Utrecht: De Tijdstroom, p. 255-258

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Tumoren van de urinewegen

van Moorselaar, R. J. A., Hulshof, M. C. C. M., Leenders, G. J. L. H., Van Herpen, C. & van Poppel, H., 2011, Leerboek Oncologie. p. 479-494

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Book

Richtlijn.Info Actuele behandelmogelijkheden van prostaatcarcinoom

van Moorselaar, R. J. A., 2009, Alphen aan den Rijn: Van Zuiden Communications B.V.

Research output: Book/ReportBookAcademicpeer-review

Article

[F-18]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells

Oprea, D., van Kanten, M. P., van Moorselaar, R. J. A., van den Eertwegh, A. J. M., van de Ven, P. M., Bijnsdorp, I. V., Hoekstra, O. S. & Geldof, A. A., 2015, In : Molecular Imaging and Biology. 17, 3, p. 319-327

Research output: Contribution to journalArticleAcademicpeer-review

ABCC4 Decreases Docetaxel and Not Cabazitaxel Efficacy in Prostate Cancer Cells In Vitro

Oprea, D., Bijnsdorp, I. V., van Moorselaar, R. J. A., van den Eertwegh, A. J. M., Hoekstra, O. S. & Geldof, A. A., 2013, In : Anticancer Research. 33, 2, p. 387-391

Research output: Contribution to journalArticleAcademicpeer-review

Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?

Jansen, B. H. E., Nieuwenhuijzen, J. A., Oprea-Lager, D. E., Yska, M. J., Lont, A. P., van Moorselaar, R. J. A. & Vis, A. N., 1 Mar 2019, In : Urologic Oncology. 37, 3, p. 181.e1-181.e6

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation

Menko, F. H., Johannesma, P. C., van Moorselaar, R. J. A., Reinhard, R., van Waesberghe, J. H. T. M., Thunnissen, E., Houweling, A. C., Leter, E. M., Waisfisz, Q., van Doorn, M. B. A., Starink, T. M., Postmus, P. E., Coull, B. J., van Steensel, M. A. M. & Gille, J. J. P., 2013, In : Familial Cancer. 12, 3, p. 373-379

Research output: Contribution to journalArticleAcademicpeer-review

Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice

Vallancien, G., Emberton, M., Alcaraz, A., Matzkin, H., van Moorselaar, R. J. A., Hartung, R., Harving, N. & Elhilali, M., 2008, In : BJU International. 101, 7, p. 847-852

Research output: Contribution to journalArticleAcademicpeer-review

A multinational phase II trial of bevacizumab with low-dose interferon-alpha 2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN

Melichar, B., Bracarda, S., Matveev, V., Alekseev, B., Ivanov, S., Zyryanov, A., Janciauskiene, R., Fernebro, E., Mulders, P., Osborne, S., Jethwa, S., Mickisch, G., Gore, M., van Moorselaar, R. J. A., Staehler, M., Magne, N. & Bellmunt, J., 2013, In : Annals of Oncology. 24, 9, p. 2396-2402

Research output: Contribution to journalArticleAcademicpeer-review

A new concept for non-invasive renal tumour ablation using real-time MRI-guided radiation therapy

Kerkhof, E. M., Raaymakers, B. W., van Vulpen, M., Zonnenberg, B. A., Bosch, J. L. H. R., van Moorselaar, R. J. A. & Lagendijk, J. J. W., 2011, In : BJU International. 107, 1, p. 63-68

Research output: Contribution to journalArticleAcademicpeer-review

A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)

Bex, A., Van Thienen, J. V., Schrier, M., Graafland, N., Kuusk, T., Hendricksen, K., Lagerveld, B., Zondervan, P., van Moorselaar, J. R. A., Blank, C., Wilgenbos, S. & Haanen, J., 1 Jul 2019, In : Future Oncology. 15, 19, p. 2203-2209 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

A protocol for urine collection and storage prior to DNA methylation analysis

Bosschieter, J., Bach, S., Bijnsdorp, I. V., Segerink, L. I., Rurup, W. F., van Splunter, A. P., Bahce, I., Novianti, P. W., Kazemier, G., van Moorselaar, R. J. A., Steenbergen, R. D. M. & Nieuwenhuijzen, J. A., 2018, In : PLoS ONE. 13, 8, p. e0200906

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?

Johannesma, P. C., Houweling, A. C., Menko, F., van de Beek, I., Reinhard, R., Gille, J. J. P., van Waesberghe, J., Thunnissen, E., Starink, T. M., Postmus, P. E. & van Moorselaar, R. J. A., Apr 2016, In : Familial Cancer. 15, 2, p. 297-300

Research output: Contribution to journalArticleAcademicpeer-review

A two-gene methylation signature for the diagnosis of bladder cancer in urine

Bosschieter, J., Nieuwenhuijzen, J. A., Hentschel, A., van Splunter, A. P., Segerink, L. I., Vis, A. N., Wilting, S. M., Lissenberg-Witte, B. I., A van Moorselaar, R. J. & Steenbergen, R. D., Feb 2019, In : Epigenomics. 11, 3, p. 337-347 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Beleid vroegdiagnostiek prostaatcarcinoom aangepast

Blanker, M., de Reijke, T., van Moorselaar, R. J. A. & Opstelten, W., 2014, In : Nederlands Tijdschrift voor Geneeskunde. 158, A8070.

Research output: Contribution to journalArticleProfessional

Bilateral renal tumour as indicator for birt-hogg-dube syndrome

Johannesma, P. C., van Moorselaar, R. J. A., Horenblas, S., van der Kolk, L. E., Thunnissen, E., van Waesberghe, J. H. T. M., Menko, F. H. & Postmus, P. E., 2014, In : Case reports in medicine. 2014, 618675.

Research output: Contribution to journalArticleAcademicpeer-review

Birt-Hogg-Dube syndrome: clinical and genetic studies of 20 families

Leter, E. M., Koopmans, A. K., Gille, J. J. P., van Os, T. A. M., Vittoz, G. G., David, E. F., Jaspars, E. H., Postmus, P. E., van Moorselaar, R. J. A., Craanen, M. E., Starink, T. M. & Menko, F. H., 2008, In : Journal of Investigative Dermatology. 128, 1, p. 45-49

Research output: Contribution to journalArticleAcademicpeer-review